BPIQ Blog

Feb 22, 20233 min read

Upcoming Pegozafermin NASH Readout!

Summary: The upcoming readout from ETNB includes Phase 2b data from the pegozafermin trial in NASH. This is a Suspected Mover for Q1...

Jun 21, 20223 min read

$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...

Jun 21, 20223 min read

$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...

Our platform helps you uncover your next biotech investment opportunity